Pandemic-Affected Trials Will Need Same Exploratory Analyses That US FDA Used To Save Aducanumab

 
• By Sue Sutter
Shipwreck view from above
FDA said it was important to salvage as much information as possible from the terminated Phase III program. • Source: Shutterstock

More from US FDA Performance Tracker

More from Regulatory Trackers